Charleston, SC -- (SBWIRE) -- 09/11/2013 -- The Team of advisers at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer. Have a look at: Applied DNA Sciences Inc (OTCBB:APDN), Exide Technologies (OTCMKTS:XIDEQ), Invivo Therapeutics Holdings Corp (OTCBB:NVIV), Advaxis, Inc. (OTCBB:ADXS)
Applied DNA Sciences Inc (OTCBB:APDN)’s shares traded down -5.66% during current trading session, hitting $0.13 recently.
The share price of APDN is currently trading with-in the range of $0.11 to $0.13. The company has a market capitalization of $2.24 billion whereas its total outstanding shares are 744.22 million. Company’s beta value stands at 1.52 points. APDN’s current trading volume is 2.24 million while its average volume is 3.09 million shares. Applied DNA Sciences, Inc. provides botanical-DNA based security and authentication solutions in Europe and the United States.
Has APDN Found The Bottom And Ready To Gain Momentum? Find Out Here
Exide Technologies (OTCMKTS:XIDEQ)’s shares traded up +0.70% during current trading session, hitting $0.289 recently. The share price of XIDEQ is currently trading with-in the range of $0.27 to $0.30. Company’s beta value stands at 2.40 points.
XIDEQ’s current trading volume is 941,725 while its average volume is 1.10 million shares. Last 5 day’s trade of the company showing a positive performance overall, with gaining stream of +37.75%. Exide Technologies manufactures and supplies lead-acid batteries for transportation and industrial applications worldwide. The company operates in four segments: Transportation Americas, Transportation Europe and Rest of World (ROW), Industrial Energy Americas, and Industrial Energy Europe and ROW.
Will XIDEQ Continue To Move Higher? Find Out Here
Invivo Therapeutics Holdings Corp (OTCBB:NVIV) is trading with an upsurge of +3.82% along with the trading price of $1.63 up till now while its today’s opening price was $1.56.
NVIV recently gained a volume of 272,839 shares while its average volume is 1.30 million shares. 52 week price range of the company is $0.94 - $6.20 while today till 10:22AM its minimum price was $1.53.
Company’s 6 month’s performance gave an optimistic outlook as it gained -25.53% while in its last 5 days its performance remained green with an upsurge of +3.82%. Invivo Therapeutics Holdings Corp., a development stage company, focuses on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral nerve injuries, and other neurotrauma conditions.
Why Should Investors Buy NVIV After The Recent Gain? Just Go Here and Find Out
Advaxis, Inc. (OTCBB:ADXS) stock hit highest price at $8.45, after starting its trade at $6.88. Company reported an increase of +20.00% at the price of $8.28 recently; its current day range is from $6.85 to $8.45.
Advaxis’s total market capitalization remained $39.81 million along with the total outstanding shares of 4.87 million. Its current volume is 52,031 in early hours of trading while if we look at its average volume than that is 29,377 shares. Advaxis, Inc., a clinical development stage biotechnology company, engages in the development of immunotherapies for cancer and infectious diseases.
What was the Moving Force behind ADXS On Bullish Run? Read This Research Report
Our team of advisers here at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the CapitalEquityReport.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
Read Full Disclaimer at: http://capitalequityreport.com/about-us/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)